Agree... should things develop as anticipated by many including seemingly company officials and those directly involved with the company (the physicians leading trials, tests etc.) I suspect media and press from around the globe would be sharing Leronlimab's lifesaving news, impact and potential without CytoDyn having to pay a penny for it.